![Image ID 159835, Lou Johnson, Bern ePrix, FIA Formula E, Jean-Eric Vergne, DS TECHEETAH, Bern, Switzerland, 22/06/2019 20:00:56 Image ID 159835, Lou Johnson, Bern ePrix, FIA Formula E, Jean-Eric Vergne, DS TECHEETAH, Bern, Switzerland, 22/06/2019 20:00:56](https://spacesuitcollections.com/images/159835_Lou_Johnson_Bern_ePrix_FIA_Formula_E_Jean-Eric_Vergne_DS_TECHEETAH_Bern_Switzerland_22_06_2019.jpg)
Image ID 159835, Lou Johnson, Bern ePrix, FIA Formula E, Jean-Eric Vergne, DS TECHEETAH, Bern, Switzerland, 22/06/2019 20:00:56
Sinan Cosarpinar, EMBA – Senior Operations Manager Solids – The Janssen Pharmaceutical Companies of Johnson & Johnson | LinkedIn
Njemba Jean-Louis – Executive Vice President – CHAMBRE DE COMMERCE ET D'INDUSTRIE SUISSE-SAO TOME ET PRINCIPE | LinkedIn
![Traci Lynn Johnson & Tiki Barber attend round 1 of US Open Tennis Championship between Roger Federer (Switzerland) and Sumit Nagal (India) at Billie Jean King National Tennis Center (Photo by Lev Traci Lynn Johnson & Tiki Barber attend round 1 of US Open Tennis Championship between Roger Federer (Switzerland) and Sumit Nagal (India) at Billie Jean King National Tennis Center (Photo by Lev](https://c8.alamy.com/comp/2ENJFPX/traci-lynn-johnson-tiki-barber-attend-round-1-of-us-open-tennis-championship-between-roger-federer-switzerland-and-sumit-nagal-india-at-billie-jean-king-national-tennis-center-photo-by-lev-radin-pacific-presssipa-usa-2ENJFPX.jpg)
Traci Lynn Johnson & Tiki Barber attend round 1 of US Open Tennis Championship between Roger Federer (Switzerland) and Sumit Nagal (India) at Billie Jean King National Tennis Center (Photo by Lev
![Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels (L) and Actelion CEO and founder Jean-Paul Clozel attend a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd Wiegmann Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels (L) and Actelion CEO and founder Jean-Paul Clozel attend a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd Wiegmann](https://l450v.alamy.com/450v/2e6j664/johnson-johnson-vice-president-and-worldwide-chairman-pharmaceuticals-joaquin-duato-l-r-actelion-ceo-and-founder-jean-paul-clozel-and-johnson-johnson-chief-scientific-officer-pharmaceuticals-paul-stoffels-pose-for-photographers-at-actelion-headquarters-in-allschwil-switzerland-january-26-2017-reutersarnd-wiegmann-2e6j664.jpg)
Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels (L) and Actelion CEO and founder Jean-Paul Clozel attend a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd Wiegmann
![Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels (L) and Actelion CEO and founder Jean-Paul Clozel attend a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd Wiegmann Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels (L) and Actelion CEO and founder Jean-Paul Clozel attend a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd Wiegmann](https://c8.alamy.com/comp/2CK5F4T/johnson-johnson-chief-scientific-officer-pharmaceuticals-paul-stoffels-l-and-actelion-ceo-and-founder-jean-paul-clozel-attend-a-news-conference-at-actelion-headquarters-in-allschwil-switzerland-january-26-2017-reutersarnd-wiegmann-2CK5F4T.jpg)
Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels (L) and Actelion CEO and founder Jean-Paul Clozel attend a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd Wiegmann
![Johnson & Johnson Vice President and Worldwide Chairman Pharmaceuticals Joaquin Duato (L-R), Actelion CEO and founder Jean-Paul Clozel and Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels pose for photographers at Johnson & Johnson Vice President and Worldwide Chairman Pharmaceuticals Joaquin Duato (L-R), Actelion CEO and founder Jean-Paul Clozel and Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels pose for photographers at](https://c8.alamy.com/comp/2CJCE8R/johnson-johnson-vice-president-and-worldwide-chairman-pharmaceuticals-joaquin-duato-l-r-actelion-ceo-and-founder-jean-paul-clozel-and-johnson-johnson-chief-scientific-officer-pharmaceuticals-paul-stoffels-pose-for-photographers-at-actelion-headquarters-in-allschwil-switzerland-january-26-2017-reutersarnd-wiegmann-2CJCE8R.jpg)
Johnson & Johnson Vice President and Worldwide Chairman Pharmaceuticals Joaquin Duato (L-R), Actelion CEO and founder Jean-Paul Clozel and Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels pose for photographers at
![KKL Luzern convention centre and concert hall (architect: Jean Nouvel, Stock Photo, Picture And Rights Managed Image. Pic. T73-697801 | agefotostock KKL Luzern convention centre and concert hall (architect: Jean Nouvel, Stock Photo, Picture And Rights Managed Image. Pic. T73-697801 | agefotostock](https://previews.agefotostock.com/previewimage/medibigoff/64a46c543385c9cfb3b9b61bdba53896/t73-697801.jpg)